So, I would say that where those valuations were a little bit overvalued because the whole market was overvalued, to the extent that the correction is coming there, I would say some fund managers would look at buying those not related to the specific case over a period of the next few days because they are good, solid operating companies which are just sentimentally getting affected by this particular case.
Wakefit IPO: Check GMP, price band, review, subscription and other details
Wakefit Innovations, known for its mattresses, is launching its IPO with a positive grey market outlook. The company is raising over Rs 1,200 crore. Despite
December 8, 2025